https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2024-results
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
annual incentive plans and is used in debt covenant computations.
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2022-results
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
annual and long-term employee incentive plans and is used in debt covenant computations.
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-news-release.pdf
AVNT-2021.09.30-News Release
1
NEWS RELEASE
FOR IMMEDIATE RELEASE
Avient Announces Record Third Quarter 2021 Results
• Sales increased 32% to $1.2 billion and GAAP EPS from continuing operations increased
to $0.57 from $0.02 in the prior year quarter
• Adjusted EPS increased 52% to $0.70 driven by record third quarter operating income in
all segments
• Increased dividend 12% to $0.95, on an annualized basis, representing the eleventh
consecutive annual increase
• Expected to continue pursuing sustainable solutions acquisitions and resume
opportunistic share repurchases with net debt to adjusted EBITDA leverage projected at
2.1x by year end
CLEVELAND – October 28, 2021 – Avient Corporation (NYSE: AVNT), a leading provider of
specialized and sustainable material solutions, today reported its third quarter results for 2021.
Refer to Attachment 7 Reconciliation of Non-GAAP Financial Measures
for details regarding adjustments to previously reported results to arrive to the pro forma financial
metrics.
In addition, operating income before the effect of special items is
a component of Avient annual and long-term employee incentive plans and is used in debt covenant computations.
https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
Microsoft PowerPoint - AVNT Mar 2022 Presentation
AVIENT CORPORATION
I N V E S T O R M E E T I N G S
(NYSE: AVNT)
M A R C H 2 0 2 2
DISCLAIMER
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
You are advised to consult any further disclosures we make
on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
We will deliver for our stakeholders through multiple value creation levers—many of
which are unique to Avient:
o Demand for sustainable solutions, healthcare, and composites, together with Clariant Color
revenue synergies, that will drive long-term revenue growth in excess of GDP
o Clariant color cost synergy capture will result in significant near-term benefit
In addition, we remain committed to increasing annual dividends in line with earnings growth and
opportunistically buying back shares, all while remaining modestly levered.
https://www.avient.com/sites/default/files/2022-07/EHS Committee Charter %28Amended July 2022%29.pdf
Duties and Responsibilities
The Committee will:
Assessment Process
• Periodically review the results of formal assessments by management of the
environmental liabilities for which the Company has known or probable environmental
exposure and the adequacy of the Company’s financial reserves for environmental
liabilities;
• Semi-annually review the status of health and safety performance of the Company;
• Semi-annually review the status of the Company’s product stewardship programs and
performance;
• Periodically review the Company’s staffing for its environmental, health and safety
assessments and compliance; and
2
• Periodically review new environmental, physical security, health and safety laws and
regulations applicable to the Company’s operations and issues or significant
developments arising from pending regulatory and citizen group activities.
Compliance Programs
• At least annually review the programs and procedures established by the Company that
monitor compliance with the Company’s policies, standards and practices, and laws
and regulations with respect to safety, health, environmental, physical security and
product stewardship, including providing oversight of the systems that are in place to
monitor and mitigate the Company’s carbon footprint and physical risks associated
with climate change;
• Periodically review with management the significant safety, health, environmental,
physical security, and product stewardship risks or exposures faced by the Company, if
any, and steps taken by management to minimize such risks and exposures to the
Company and its constituencies;
• At least annually review the status of the Company’s environmental and safety audit
process, assessing compliance with Company policies, standards, practices, laws and
regulations; and
• Periodically review claims, demands, administrative orders and legal proceedings
against the Company regarding safety, health, environmental, physical security and
product stewardship matters.
The Committee will meet at least two times a year and at such other times as may be
requested by its Chair.
3
• The Committee will annually review its charter and recommend any changes to the
Governance and Corporate Responsibility Committee.
https://www.avient.com/sites/default/files/2019-12/Fermium_IR_Deck_12.16.19_for_Website.pdf
Investor Day
FERMIUM
RESEARCH
MARKETING TRIP
D E C E M B E R 1 6 , 2 0 1 9
FORWARD LOOKING STATEMENTS
PolyOne Corporation 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to
the Securities and Exchange Commission.
In addition, operating income
before special items and adjusted EPS are components of various PolyOne
annual and long-term employee incentive plans
https://www.avient.com/sites/default/files/2024-08/Avient AUG 2024 Investor Presentation- w Non-GAAP.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Disruptions or inefficiencies in our supply chain, logistics, or operations;
• Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Demand for our products and services;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA;
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.”
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
In addition, operating
income before the effect of special items is a component of Avient’s annual incentive plans and is used in debt covenant
computations.
https://www.avient.com/news/advanced-technologies-and-sustainable-material-innovations-avient-debut-chinaplas-2024
At Chinaplas, we will demonstrate our expertise to meet these trends and complex challenges, including our annual color forecasting guide and customized colorants and additives, thermoplastic elastomers (TPEs), and specialty engineered materials for uses in a wide range of industries.”
ColorForward™ 2025: the 19th annual edition of Avient’s acclaimed color trend forecast, illustrating a palette of 20 mid-tone colors in four major trend themes, predicted to elicit high consumer response and inspire brand owners and designers of plastic products
https://www.avient.com/sites/default/files/2024-07/avient-human-rights-position-statement-updated-july-2021 %286%29.pdf
To ensure consistent
communication and compliance, all associates globally are expected to complete our Code of Conduct
training on an annual basis on various aspects of our Code, including but not limited to human rights.
Our
Code of Conduct is available in over 20 languages and can be found at:
https://www.avient.com/company/policies-and-governance/code-conduct
Our Ethics Hotline is available 24 hours a day, 7 days a week, by phone or web, for our associates and
the community to report any concerns or make inquiries.
Those making reports can remain anonymous.